Literature DB >> 33040748

Surgeon choice in the use of postdischarge antibiotics for prophylaxis following mastectomy with and without breast reconstruction.

David K Warren1, Katelin B Nickel1, Christopher J Hostler2,3, Katherine Foy2, Jennifer H Han4,5,6, Pam Tolomeo5, Ian R Banks1, Victoria J Fraser1, Margaret A Olsen1,7.   

Abstract

Multiple guidelines recommend discontinuation of prophylactic antibiotics <24 hours after surgery. In a multicenter, retrospective cohort of 2,954 mastectomy patients ± immediate breast reconstruction, we found that utilization of prophylactic postdischarge antibiotics varied dramatically at the surgeon level among general surgeons and was virtually universal among plastic surgeons.

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33040748      PMCID： PMC8039058          DOI： 10.1017/ice.2020.462

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  9 in total

1.  Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance.

Authors:  S Harbarth; M H Samore; D Lichtenberg; Y Carmeli
Journal:  Circulation       Date:  2000-06-27       Impact factor: 29.690

2.  Current practice among plastic surgeons of antibiotic prophylaxis and closed-suction drains in breast reconstruction: experience, evidence, and implications for postoperative care.

Authors:  Brett T Phillips; Eric D Wang; Joshua Mirrer; Steven T Lanier; Sami U Khan; Alexander B Dagum; Duc T Bui
Journal:  Ann Plast Surg       Date:  2011-05       Impact factor: 1.539

3.  Comorbidity measures for use with administrative data.

Authors:  A Elixhauser; C Steiner; D R Harris; R M Coffey
Journal:  Med Care       Date:  1998-01       Impact factor: 2.983

Review 4.  Antimicrobial Stewardship: A Call to Action for Surgeons.

Authors:  Massimo Sartelli; Therese M Duane; Fausto Catena; Jeffrey M Tessier; Federico Coccolini; Lillian S Kao; Belinda De Simone; Francesco M Labricciosa; Addison K May; Luca Ansaloni; John E Mazuski
Journal:  Surg Infect (Larchmt)       Date:  2016-11-09       Impact factor: 2.150

5.  ASPS clinical practice guideline summary on breast reconstruction with expanders and implants.

Authors:  Amy Alderman; Karol Gutowski; Amy Ahuja; Diedra Gray
Journal:  Plast Reconstr Surg       Date:  2014-10       Impact factor: 4.730

6.  National practice patterns in preoperative and postoperative antibiotic prophylaxis in breast procedures requiring drains: survey of the American Society of Breast Surgeons.

Authors:  Rushin D Brahmbhatt; Marianne Huebner; Jeffrey S Scow; W Scott Harmsen; Judy C Boughey; Ann M Harris; Donna Goede; James W Jakub; Tina J Hieken; Amy C Degnim
Journal:  Ann Surg Oncol       Date:  2012-07-06       Impact factor: 5.344

7.  Association of Duration and Type of Surgical Prophylaxis With Antimicrobial-Associated Adverse Events.

Authors:  Westyn Branch-Elliman; William O'Brien; Judith Strymish; Kamal Itani; Christina Wyatt; Kalpana Gupta
Journal:  JAMA Surg       Date:  2019-07-01       Impact factor: 14.766

8.  Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017.

Authors:  Sandra I Berríos-Torres; Craig A Umscheid; Dale W Bratzler; Brian Leas; Erin C Stone; Rachel R Kelz; Caroline E Reinke; Sherry Morgan; Joseph S Solomkin; John E Mazuski; E Patchen Dellinger; Kamal M F Itani; Elie F Berbari; John Segreti; Javad Parvizi; Joan Blanchard; George Allen; Jan A J W Kluytmans; Rodney Donlan; William P Schecter
Journal:  JAMA Surg       Date:  2017-08-01       Impact factor: 14.766

9.  Extended Prophylactic Antibiotics for Mastectomy with Immediate Breast Reconstruction: A Meta-analysis.

Authors:  Yang Hai; Weelic Chong; Melissa A Lazar
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-01-27
  9 in total
  1 in total

1.  Feasibility and safety of discontinuation of isolation precaution policy for coronavirus disease 2019 (COVID-19) patients from COVID-19 units to general medical units in Thailand.

Authors:  Anucha Apisarnthanarak; David K Warren; David J Weber
Journal:  Infect Control Hosp Epidemiol       Date:  2021-07-21       Impact factor: 6.520
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.